The IDEHALER®-POCKET offers a virtual valve nebulization system.
In terms of performance, the IDEHALER®-POCKET allows to:
- increase the inhalable ratio - up to 77%,
- deliver a 4µm particle size aerosol.
The IDEHALER®-POCKET offers the advantage to be
- very small and portable,
- easy to use.
Scientific communication
!NEW! Feasibility study of OSCN- and Lactoferrin (Meveol®) nebulization for cystic fibrosis patients. Perrotto S., Le Guellec S., Vecellio L., Fichant E., Stordeur P., Bordeau P. and Perraudin JP. 34 th ECFS, 2011 and DDL21, 2010 with abstract available on JAM, 2011, 24(6):330. Poster PDF file
Testing of nebulizers for delivering magnesium sulfate to pediatric asthma patients in the emergency department. Coates AL., Leung K., Vecellio L., Schuh S. Respir Care. 2011 Mar;56(3):314-8. Pubmed abstract
Preliminary study of a new antibiotic for nebulization. Vecellio L. Oral poster presentation, ECFS, 2009. PDF file
In vitro performances of an innovative device for mesh nebulizer. Vecellio L., Diot P., Le Guellec S., Chantrel G. ISAM, 2007. Poster PDF file
In the pipeline: Clinical trials with IDEHALER®-POCKET
September, 2011
Aerodrug announces the success of the clinical study evaluating the IDEHALER®-POCKET device for the nebulization of an antibiotic in CF patients.
January, 2012
The IDEHALER®POCKET/AERONEB®Go was chosen (april, 2011) by the canadian multicenter clinical trial as the nebulization system for magnesium sulfate (MgSO4) in pediatric asthmatic patients.
This study is currently recruiting participants.
Press releases
September, 2009.
The Idehaler®Pocket® is selected by ALAXIA to nebulize Meveol®, a new orphan drug, anti-inflammatory and anti-microbial, for the treatment of cystic fibrosis.
21th November 2009 - 7:00 pm
FR3 French National channel - 2’21" Frederic Llopp
Click here to view the reportage (in french).
14th September, 2009
TLM French regional channel - 2’05" Bertrand Frachon